Global Organ Preservation and Perfusion Solution Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Organ Preservation and Perfusion Solution Market Insights, Forecast to 2034
Organ preservation and perfusion solutions are specialized solutions used to maintain the viability and function of organs during transplantation or storage for medical purposes. These solutions are designed to provide optimal conditions for the preservation and transportation of organs from the donor to the recipient, ensuring minimal damage and maximizing the chances of a successful transplant.
Market Analysis and InsightsGlobal Organ Preservation and Perfusion Solution Market
Global Organ Preservation and Perfusion Solution market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Organ Preservation and Perfusion Solution industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Organ Preservation and Perfusion Solution key companies include 21st Century Medicine, Bridge to Life Limited, BioLife Solutions, Dr. Franz Köhler Chemie GmbH, XVIVO Perfusion, Artivion, Preservation Solutions, Bristol Myers Squibb and Teva Pharmaceuticals, etc. 21st Century Medicine, Bridge to Life Limited, BioLife Solutions are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Organ Preservation and Perfusion Solution were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Organ Preservation and Perfusion Solution market and estimated to attract more attentions from industry insiders and investors.
Organ Preservation and Perfusion Solution can be divided into Static Cold Storage (SCS), Hypothermic Perfusion Preservation (HPP), Hypothermic Machine Preservation (HMP) and Others, etc. Static Cold Storage (SCS) is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Organ Preservation and Perfusion Solution is widely used in various fields, such as Kidney, Liver, Heart and Lung, etc. Kidney provides greatest supports to the Organ Preservation and Perfusion Solution industry development. In 2022, global % revenue of Organ Preservation and Perfusion Solution went into Kidney filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Organ Preservation and Perfusion Solution market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Organ Preservation and Perfusion Solution market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
21st Century Medicine
Bridge to Life Limited
BioLife Solutions
Dr. Franz Köhler Chemie GmbH
XVIVO Perfusion
Artivion
Preservation Solutions
Bristol Myers Squibb
Teva Pharmaceuticals
Lifeline Scientific
Advanced Life Solutions
Organ Recovery Systems
Transmedics
Accord Healthcare
Segment by Type
Static Cold Storage (SCS)
Hypothermic Perfusion Preservation (HPP)
Hypothermic Machine Preservation (HMP)
Others
Kidney
Liver
Heart
Lung
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Organ Preservation and Perfusion Solution introduction, etc. Organ Preservation and Perfusion Solution Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Organ Preservation and Perfusion Solution
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Organ Preservation and Perfusion Solution Market
Global Organ Preservation and Perfusion Solution market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Organ Preservation and Perfusion Solution industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Organ Preservation and Perfusion Solution key companies include 21st Century Medicine, Bridge to Life Limited, BioLife Solutions, Dr. Franz Köhler Chemie GmbH, XVIVO Perfusion, Artivion, Preservation Solutions, Bristol Myers Squibb and Teva Pharmaceuticals, etc. 21st Century Medicine, Bridge to Life Limited, BioLife Solutions are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Organ Preservation and Perfusion Solution were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Organ Preservation and Perfusion Solution market and estimated to attract more attentions from industry insiders and investors.
Organ Preservation and Perfusion Solution can be divided into Static Cold Storage (SCS), Hypothermic Perfusion Preservation (HPP), Hypothermic Machine Preservation (HMP) and Others, etc. Static Cold Storage (SCS) is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Organ Preservation and Perfusion Solution is widely used in various fields, such as Kidney, Liver, Heart and Lung, etc. Kidney provides greatest supports to the Organ Preservation and Perfusion Solution industry development. In 2022, global % revenue of Organ Preservation and Perfusion Solution went into Kidney filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Organ Preservation and Perfusion Solution market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Organ Preservation and Perfusion Solution market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
21st Century Medicine
Bridge to Life Limited
BioLife Solutions
Dr. Franz Köhler Chemie GmbH
XVIVO Perfusion
Artivion
Preservation Solutions
Bristol Myers Squibb
Teva Pharmaceuticals
Lifeline Scientific
Advanced Life Solutions
Organ Recovery Systems
Transmedics
Accord Healthcare
Segment by Type
Static Cold Storage (SCS)
Hypothermic Perfusion Preservation (HPP)
Hypothermic Machine Preservation (HMP)
Others
Segment by Application
Kidney
Liver
Heart
Lung
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Organ Preservation and Perfusion Solution introduction, etc. Organ Preservation and Perfusion Solution Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Organ Preservation and Perfusion Solution
Chapter 13Methodology and Data Sources adopted by MRAResearch